Filing Details

Accession Number:
0001179110-18-012085
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-09 14:14:22
Reporting Period:
2018-10-05
Accepted Time:
2018-10-09 14:14:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509669 S Philip Low 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Chief Science Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-09-07 294 $0.00 325,745 No 4 G Direct
Common Stock Disposition 2018-10-05 5,928 $15.56 319,817 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 184,985 Indirect By spouse trust
Footnotes
  1. Represents the sale of 5,928 shares in multiple transactions ranging in price from $15.1400 to $15.9200, resulting in a weighted-average price of $15.5597. The 5,928 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 20,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.